gms | German Medical Science

MAINZ//2011: 56. GMDS-Jahrestagung und 6. DGEpi-Jahrestagung

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V.
Deutsche Gesellschaft für Epidemiologie e. V.

26. - 29.09.2011 in Mainz

Global strategies for cancer: the role of registries

Meeting Abstract

Search Medline for

  • David Forman - Head, Section of Cancer Information, International Agency for Research on Cancer, Lyon, France

Mainz//2011. 56. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds), 6. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi). Mainz, 26.-29.09.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. Doc11gmds611

doi: 10.3205/11gmds611, urn:nbn:de:0183-11gmds6119

Published: September 20, 2011

© 2011 Forman.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



In September 2011 the United Nations General Assembly will hold a Summit on Noncommunicable Diseases (NCDs), for which cancer will be one of the major considerations. The Summit will provide an unprecedented opportunity for generating high-level political commitment in support of national and regional initiatives to strengthen cancer registration in LMICs as part of cancer control programmes. The recent WHO “Global Status Report on Noncommunicable Diseases 2010” stresses that: ”Reliable data on NCD morbidity are scarce in many countries. Accurate information on morbidity is important for policy and programme development. This is particularly the case for cancer where data on the incidence and type of cancer are essential for planning cancer control programmes”. More specifically on cancer, the World Cancer Declaration promoted by the Union for International Cancer Control (UICC) sets as Target 2: “the improvement of the measurement of the global cancer burden and of the impact of cancer control interventions”. The case for the need for good quality cancer registration worldwide is thus beginning to reach a wide audience. This presentation will consider what is understood about the current global burden of cancer, from the GLOBOCAN database, its distribution in different regions of the world and likely future scenarios based on demographic projections to 2030. The case of cervical cancer will be specifically demonstrated as a major cause of morbidity and mortality in many developing countries for which low-cost screening interventions can make a significant impact. Results are primarily based on data supplied by cancer registries and the quality of and limitations in this source of information will be discussed together with proposals to improve the situation. The use of information on worldwide patterns of cancer will also be considered from the perspective of a driver of future epidemiological research programmes.